Every material Form 8-K Genworth Financial filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Genworth reported third-quarter 2025 net income available to common stockholders of $116 million, or $0.28 per diluted share, up from $51 million in the prior quarter and $85 million a year earlier. Adjusted operating income fell to $17 million, or $0.04 per diluted share, from $68 million in the prior quarter and $48 million a year earlier. The company also announced a new $350 million share repurchase authorization, and the GAAP result was helped by $78 million of net investment gains and a $34 million tax benefit.
Net income available to common stockholders was $116 million ($0.28 diluted), versus $51 million in Q2 2025 and $85 million in Q3 2024.
Adjusted operating income was $17 million ($0.04 diluted), versus $68 million in Q2 2025 and $48 million in Q3 2024.
Net income included a $34 million tax benefit and $78 million of net investment gains; Long-Term Care Insurance adjusted operating loss was $100 million.
Board authorized a new $350 million share repurchase program; $76 million was executed in the quarter.
Genworth reported second-quarter 2025 results, with net income available to common stockholders of $51 million, or $0.12 per diluted share, compared with $76 million, or $0.17, a year earlier. Adjusted operating income was $68 million, or $0.16 per diluted share, down from $125 million a year earlier but up from $51 million in the first quarter of 2025, and total revenues rose slightly year over year to $1,796 million.
Net income available to common stockholders was $51 million ($0.12 per diluted share) in Q2 2025, versus $76 million ($0.17) in Q2 2024 and $54 million ($0.13) in Q1 2025.
Adjusted operating income was $68 million ($0.16 per diluted share), versus $125 million ($0.28) in Q2 2024 and $51 million ($0.12) in Q1 2025.
Total revenues were $1,796 million, compared with $1,786 million in Q2 2024.
Genworth repurchased $30 million of shares in the quarter, leaving $80 million remaining in the authorization at June 30, 2025.
Genworth reported first quarter 2025 net income of $54 million, or $0.13 per diluted share, down from $139 million, or $0.31 per diluted share, in the first quarter of 2024. Adjusted operating income was $51 million, or $0.12 per diluted share, compared with $85 million, or $0.19, a year earlier, though it improved from $15 million in the fourth quarter of 2024. The results show lower earnings year over year, with Enact the main earnings contributor.
Net income $54 million ($0.13 per diluted share) in Q1 2025 vs. $139 million ($0.31) in Q1 2024 and a $1 million loss in Q4 2024
Adjusted operating income $51 million ($0.12 per diluted share) vs. $85 million ($0.19) in Q1 2024
Enact raised its quarterly dividend to $0.21 per share from $0.185 and announced a new buyback authorization of up to $350 million
Holding company cash and liquid assets were $211 million at March 31, 2025, down from $294 million at December 31, 2024
Genworth Financial increased its board to 10 directors and elected Steven C. Van Wyk, former Group Chief Information Officer of HSBC, as a new independent director effective March 19, 2025. The filing says he will stand for election at the 2025 Annual Meeting of Stockholders on May 22, 2025, and the board has not yet set his committee assignments.
Board size increased from 9 to 10 directors; Van Wyk elected March 19, 2025
Van Wyk was Group CIO of HSBC; he retired in 2024 and previously held CIO roles at PNC, ING and Morgan Stanley
Van Wyk will stand for election at the Annual Meeting of Stockholders scheduled for May 22, 2025
Board determined he is independent under NYSE listing standards; committee appointments to be decided later
Genworth reported fourth-quarter 2024 net loss of $1 million, or breakeven per diluted share, compared with a $212 million loss a year earlier but down from $85 million of net income in the third quarter. Full-year 2024 net income was $299 million, or $0.68 per diluted share, up from $76 million in 2023, while quarterly total revenues fell to $1.78 billion from $1.91 billion.
Q4 2024 adjusted operating income was $15 million, or $0.04 per diluted share, versus a $230 million loss in Q4 2023 and $48 million in Q3 2024.
Full-year 2024 adjusted operating income was $273 million, or $0.62 per diluted share, compared with $41 million in 2023.
Enact reported Q4 2024 adjusted operating income of $137 million; Long-Term Care Insurance adjusted operating loss was $104 million.
The company repurchased $51 million of common stock in Q4 2024 and $565 million program-to-date through February 14, 2025.
Enact Holdings, Inc., a publicly traded subsidiary of Genworth Financial, released its financial results for the quarter ended December 31, 2024, on February 4, 2025, attached as Exhibit 99.1. The filing contains no figures from those results, so its performance cannot be judged from this 8-K alone.
Enact Holdings (Nasdaq: ACT) issued its Q4 2024 results press release on February 4, 2025
Genworth plans to release its quarter ended December 31, 2024 earnings after market close on February 18, 2025
Genworth's earnings conference call is scheduled for February 19, 2025 at 9:00 a.m. ET
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Genworth Financial filing is on SEC EDGAR ↗. 8-K briefs of other companies →